Articles By Rob Wright, Chief Editor

A Behind The Scenes Look Into Planning For BIO 2018 — Thus Far
A Behind The Scenes Look Into Planning For BIO 2018 — Thus Far A behind the scenes look into the educational planning for the 2018 BIO International Convention in Boston.  Continue Reading...
  • Are You Ready For The Future Of Biopharma Manufacturing?
    Are You Ready For The Future Of Biopharma Manufacturing?

    In last’s year’s manufacturing outlook we delved into biopharma’s manufacturing capacity crunch. While lack of manufacturing capacity remains a challenge for the industry, the future of biopharma manufacturing has never looked so bright, and there are a variety of reasons why.

  • Are You Ready For The Future Of Biopharma Manufacturing?
    Are You Ready For The Future Of Biopharma Manufacturing?

    In last’s year’s manufacturing outlook we delved into biopharma’s manufacturing capacity crunch. While lack of manufacturing capacity remains a challenge for the industry, the future of biopharma manufacturing has never looked so bright, and there are a variety of reasons why.

  • Back To The Future
    Back To The Future

    I admit I have always taken pleasure in pondering what the future might hold and thus relish opportunities to watch TED Talks or read books by futurists like Ray Kurzweil. So when John Cumbers, Ph.D., and Karl Schmieder asked if I’d be willing to preview their book, What’s Your Bio Strategy? prior to publication, I was all in.

  • Prophecy & Prognostication — A Charting Of Biopharma’s Future
    Prophecy & Prognostication — A Charting Of Biopharma’s Future

    How do we best predict who or what might have a big impact on the biopharma industry in 2018? Although there are no guarantees with this kind of prognostication, we felt seeking the opinions of experienced top biopharma executives would be a good place to start.

  • Will Neuroscience R&D Be The Next Big Thing — Again?
    Will Neuroscience R&D Be The Next Big Thing — Again?

    Merck’s VP and head of neuroscience research, Darryle Schoepp, shares insight as to why there is increased interest in developing therapeutics targeting neurodegenerative diseases.

  • What Kinds Of Deals To Expect At JPM In 2018
    What Kinds Of Deals To Expect At JPM In 2018

    Merck’s SVP of BD and licensing, Ben Thorner, provides insight into what type of deals to expect at the 36th Annual J.P. Morgan Healthcare Conference.

  • 7 Tips To Get You Ready For JPM 2018
    7 Tips To Get You Ready For JPM 2018

    Seven tips to get you ready for attending the 36th Annual J.P. Morgan Healthcare Conference.

  • Why Semantics Matter In Pharma
    Why Semantics Matter In Pharma

    As children, we were all taught the phrase, “Sticks and stones may break my bones, but words will never hurt me.” But as adults, we all know that words can hurt and, more importantly, that semantics do matter. I was reminded of the latter on two occasions recently.

  • From Startup To Acquisition By Lilly, And Everything In Between
    From Startup To Acquisition By Lilly, And Everything In Between

    “Going to medical school, completing my residency, and pursuing my Ph.D. were a cake walk in comparison to being the CEO of a biotech,” says Daniel Skovronsky, M.D., Ph.D., who talks about his journey from working out of his car to selling his company for $300 million and then going to work for Lilly.

Rob Wright

Rob Wright



Rob Wright is the chief editor of Life Science Leader magazine. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, co-chaired, moderated, and served as a speaker at industry and academic conferences and is the past co-chair for the 2015 BIO International conference educational planning committee. Wright’s 100+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma.